No Data
No Data
Vicore Expands and Strengthens Its Board of Directors
STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of
FFIE, OGEN and CCLD Among Mid-day Movers
Telesis Bio in Jeopardy: Risks of Nasdaq Delisting and Financial Instability Loom
Express News | Telesis Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results
NOTV, BFRI and CPOP Among Pre-market Losers
Telesis Bio Reports Q1 Results
No Data
Jaguar8 : Oh yes yes yes pls